AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iLIVER Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Imaging of pregnancy-related liver diseases

Zongxue LiZe ZhangJing YuXia DuPinggui LeiZhibing RuanBo Gao( )
Department of Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou, China
Show Author Information

Abstract

Pregnancy-related liver diseases are the most frequent cause of liver dysfunction in pregnancy and pose a real threat to fetal and maternal survival. Although hepatobiliary disorders are uncommon in pregnancy, they may be severe enough to cause risk to both the mother and fetus. There are five different types of liver disease that are unique to pregnancy, including hyperemesis gravidarum, intrahepatic cholestasis of pregnancy, preeclampsia, hemolysis, elevated liver enzyme, and low platelet count syndrome, and acute fatty liver of pregnancy. Ultrasound, computed tomography, and magnetic resonance imaging play important roles in the rapid diagnosis and evaluation of complications. An accurate diagnosis can guide further treatment or the induction of labor to prevent intrauterine fetal death. This review highlights the pathogenesis, clinical features, imaging features, and treatment of pregnancy-related liver diseases with the aim of enhancing awareness of these rare but potentially life-threatening diseases of pregnancy.

References

[1]

Ch'ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002;51:876–80.

[2]

Pan C, Perumalswami PV. Pregnancy-related liver diseases. Clin Liver Dis 2011;15: 199–208.

[3]

Abduljalil K, Furness P, Johnson TN, et al. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling. Clin Pharmacokinet 2012;51:365–96.

[4]

Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet 2010;375: 594–605.

[5]

Bacak SJ, Thornburg LL. Liver failure in pregnancy. Crit Care Clin 2016;32:61–72.

[6]

Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol 2016;64:933–45.

[7]

Ma K, Berger D, Reau N. Liver diseases during pregnancy. Clin Liver Dis 2019;23: 345–61.

[8]

Committee on Obstetric P. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2017;130:e210–6.

[9]

Lee SY, Rhee CM, Leung AM, et al. A review: radiographic iodinated contrast mediainduced thyroid dysfunction. J Clin Endocrinol Metab 2015;100:376–83.

[10]

Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403–8.

[11]

Nahon P, Thabut G, Ziol M, et al. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 2006 Dec;101(12):2744–51.

[12]

Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005 Oct;42(4):838–45.

[13]

Ammon FJ, Kohlhaas A, Elshaarawy O, et al. Liver stiffness reversibly increases during pregnancy and independently predicts preeclampsia. World J Gastroenterol 2018 Oct 14;24(38):4393–402.

[14]

Fejzo MS, Trovik J, Grooten IJ, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Prim 2019;5:62.

[15]

Garcia-Romero CS, Guzman C, Cervantes A, et al. Liver disease in pregnancy: medical aspects and their implications for mother and child. Ann Hepatol 2019;18:553–62.

[16]

Kong X, Kong Y, Zhang F, et al. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: a metaanalysis (a prisma-compliant study). Medicine (Baltim) 2016 Oct;95(40):e4949.

[17]

Lee RH, Geenes VL, Williamson C. Primum non nocere: stillbirth rate in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2015 Mar;212(3):414.

[18]

Wei W, Hu YY. Expression of hypoxia-regulated genes and glycometabolic genes in placenta from patients with intrahepatic cholestasis of pregnancy. Placenta 2014 Sep;35(9):732–6.

[19]

Stander H, Cadden J. Acute yellow atrophy of the liver in pregnancy. Am J Obstet Gynecol 1934;28:61–9.

[20]

Adams RH, Gordon J, Combes B. Hyperemesis gravidarum. I. Evidence of hepatic dysfunction. Obstet Gynecol 1968;31:659–64.

[21]

Mikolasevic I, Filipec-Kanizaj T, Jakopcic I, et al. Liver disease during pregnancy: a challenging clinical issue. Med Sci Mon Int Med J Exp Clin Res 2018;24:4080–90.

[22]

Lee NM, Saha S. Nausea and vomiting of pregnancy. Gastroenterol Clin N Am 2011; 40:309–34.

[23]

Niemeijer MN, Grooten IJ, Vos N, et al. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol 2014;211:150 e1–e15.

[24]

Williamson C, Hems LM, Goulis DG, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 2004;111:676–81.

[25]

Piatek K, Kurzawinska G, Magielda J, et al. The role of ABC transporters' gene polymorphism in the etiology of intrahepatic cholestasis of pregnancy. Ginekol Pol 2018;89:393–7.

[26]

Floreani A, Carderi I, Paternoster D, et al. Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis 2008;40:366–70.

[27]

Vitale G, Gitto S, Vukotic R, et al. Familial intrahepatic cholestasis: new and wide perspectives. Dig Liver Dis 2019;51:922–33.

[28]

Sticova E, Jirsa M, Pawlowska J. New insights in genetic cholestasis: from molecular mechanisms to clinical implications. Chin J Gastroenterol Hepatol 2018; 2018:2313675.

[29]

Yayi H, Danqing W, Shuyun L, et al. Immunologic abnormality of intrahepatic cholestasis of pregnancy. Am J Reprod Immunol 2010;63:267–73.

[30]

Amaral LM, Wallace K, Owens M, et al. Pathophysiology and current clinical management of preeclampsia. Curr Hypertens Rep 2017;19:61.

[31]
Martin Jr JN, Morris RF. Preeclampsia-spectrum hypertensive disorders of pregnancy: gestational hypertension, preeclampsia, eclampsia, chronic hypertension, and HELLP syndrome. Sex Differ Cardiovasc Physiol Pathophysiol 2019:121–36. Elsevier.
[32]

Geldenhuys J, Rossouw TM, Lombaard HA, et al. Disruption inthe regulationof immune responses in the placental subtype of preeclampsia. Front Immunol 2018;9:1659.

[33]

Cornelius DC, Cottrell J, Amaral LM, et al. Inflammatory mediators: a causal link to hypertension during preeclampsia. Br J Pharmacol 2019;176:1914–21.

[34]

Campbell N, LaMarca B, Cunningham Jr MW. The role of agonistic autoantibodies to the angiotensin Ⅱ type 1 receptor (AT1-AA) in pathophysiology of preeclampsia. Curr Pharmaceut Biotechnol 2018;19:781–5.

[35]

van Lieshout L, Koek GH, Spaanderman MA, et al. Placenta derived factors involved in the pathogenesis of the liver in the syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP): a review. Pregnancy Hypertens 2019; 18:42–8.

[36]

Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol 2014;60: 1063–74.

[37]

Zelesco M, Welman CJ, Abbott S. Preliminary clinical experience with shear wave dispersion (SWD) imaging of the liver. Ultrasound Med Biol 2019;45:S25.

[38]

Treem WR, Shoup ME, Hale DE, et al. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency. Am J Gastroenterol 1996;91:2293–300.

[39]

Fejzo MS, Trovik J, Grooten IJ, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Prim 2019;5(1):62.

[40]

Ahmed KT, Almashhrawi AA, Rahman RN, et al. Liver diseases in pregnancy: diseases unique to pregnancy. World J Gastroenterol 2013;19(43):7639–46.

[41]

Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for diagnosis and treatment of intrahepatic cholestasis of pregnancy (2015). Zhonghua Fu Chan Ke Za Zhi 2015;50:481–5.

[42]

Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019;393(10174): 899–909.

[43]

Labbe C, Delesalle C, Creveuil C, et al. Cholestases intrahepatiques gravidiques (CIG) précoces et tardives: étude des complications materno-fœtales[Early and later intrahepatic cholestasis of pregnancy (ICP): study of adverse pregnancy outcomes]. Gynecol Obstet Fertil Senol 2018 Apr;46(4):388–94.

[44]

Guarino M, Cossiga V, Morisco F. The interpretation of liver function tests in pregnancy. Best Pract Res Clin Gastroenterol 2020 Feb-Apr;44–45:101667.

[45]

Lim E, Mouyis M, MacKillop L. Liver diseases in pregnancy. Clin Med 2021 Sep; 21(5):e441–5.

[46]

Alghamdi S, Fleckenstein J. Liver disease in pregnancy and transplant. Curr Gastroenterol Rep 2019 Jul 25;21(9):43.

[47]

Naoum EE, Leffert LR, Chitilian HV, et al. Acute fatty liver of pregnancy: pathophysiology, anesthetic implications, and obstetrical management. Anesthesiology 2019 Mar;130(3):446–61.

[48]

Azzaroli F, Mazzella G, Marchesini G, et al. Fatty liver in pregnancy: a narrative review of two distinct conditions. Expet Rev Gastroenterol Hepatol 2020 Feb;14(2): 127–35.

[49]

Braga A, Obeica B, Werner H, et al. A twin pregnancy with a hydatidiform mole and a coexisting live fetus: prenatal diagnosis, treatment, and follow-up. J Ultrason 2017;17:299–305.

[50]

Lin LH, Polizio R, Fushida K, et al. Imaging in gestational trophoblastic disease. Semin Ultrasound CT MR 2019 Aug;40(4):332–49.

[51]

Jauniaux E, Memtsa M, Johns J, et al. New insights in the pathophysiology of complete hydatidiform mole. Placenta 2018;62:28–33.

[52]

Shaaban AM, Rezvani M, Haroun RR, et al. Gestational trophoblastic disease: clinical and imaging features. Radiographics 2017;37:681–700.

[53]

Oudman E, Wijnia JW, Oey M, et al. Wernicke's encephalopathy in hyperemesis gravidarum: a systematic review. Eur J Obstet Gynecol Reprod Biol 2019;236:84–93.

[54]

Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR Am J Roentgenol 2009;192:501–8.

[55]

Mohr-Sasson A, Schiff E, Suday RR, et al. The yield of abdominal ultrasound in the evaluation of elevated liver enzymes during the second and the third trimester of pregnancy. Gynecol Obstet Invest 2017;82:517–20.

[56]

Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15:2049–66.

[57]

Wood AM, Livingston EG, Hughes BL, et al. Intrahepatic cholestasis of pregnancy: a review of diagnosis and management. Obstet Gynecol Surv 2018;73:103–9.

[58]

Suri V, Jain R, Aggarwal N, et al. Usefulness of fetal monitoring in intrahepatic cholestasis of pregnancy: a prospective study. Arch Gynecol Obstet 2012 Dec; 286(6):1419–24.

[59]

Beyls C, Decock S, Arts J, et al. Liver disease late in pregnancy without preeclampsia. Acta gastro-enterologica Belgica 2017;80:53–7.

[60]

Mould A, Abbott S, Welman CJ. HELLP syndrome: an ultrasound case of geographically altered liver parenchymal echogenicity with shear wave elastography, shear wave dispersion and attenuation imaging correlation. Australasian Journal of Ultrasound in Medicine 2020;23.

[61]

Cetin O, Karaman E, Arslan H, et al. Evaluation of maternal liver elasticity by acoustic radiation force impulse elastosonography in hypertensive disorders of pregnancy: a preliminary descriptive study. J Matern Fetal Neonatal Med 2017 Oct; 30(19):2281–6.

[62]

Plowman RS, Javidan-Nejad C, Raptis CA, et al. Imaging of pregnancy-related vascular complications. Radiographics 2017;37:1270–89.

[63]

Hacein-Bey L, Varelas PN, Ulmer JL, et al. Imaging of cerebrovascular disease in pregnancy and the puerperium. AJR Am J Roentgenol 2016;206:26–38.

[64]

Nakai A, Asakura H, Oya A, et al. Pulsed Doppler US findings of renal interlobar arteries in pregnancy-induced hypertension. Radiology 1999;213:423–8.

[65]

Karcaaltincaba M, Haliloglu M, Akpinar E, et al. Multidetector CT and MRI findings in periportal space pathologies. Eur J Radiol 2007;61:3–10.

[66]

Perronne L, Dohan A, Bazeries P, et al. Hepatic involvement in HELLP syndrome: an update with emphasis on imaging features. Abdom Imag 2015;40:2839–49.

[67]

Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008;57:951–6.

[68]

Ong EM, Drukteinis JS, Peters HE, et al. Multimodality imaging of hepato-biliary disorders in pregnancy: a pictorial essay. Emerg Radiol 2009;16:357–63.

[69]

Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29:1705–13.

[70]

Chan WK, Nik Mustapha NR, Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2014;29:1470–6.

[71]

Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2012 Dec; 107(12):1862–71.

[72]

Cui J, Heba E, Hernandez C, et al. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsyproven nonalcoholic fatty liver disease: a prospective study. Hepatology 2016;63: 453–61.

[73]

Caussy C, Alquiraish MH, Nguyen P, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 2018;67:1348–59.

[74]

Tang A, Desai A, Hamilton G, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416–25.

[75]

Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 2017;152:598–607.

[76]

Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328–57.

[77]

Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 2012;48:441–6.

[78]

Park HJ, Park B, Lee SS. Radiomics and deep learning: hepatic applications. Korean J Radiol 2020;21:387–401.

[79]

Wang K, Lu X, Zhou H, et al. Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study. Gut 2019 Apr;68(4):729–41.

[80]

Lambin P, Leijenaar R, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017;14:749–62.

[81]

Spann A, Yasodhara A, Kang J, et al. Applying machine learning in liver disease and transplantation: a comprehensive review. Hepatology 2020;71:1093–105.

[82]

Kremer AE, Bolier R, Dixon PH, et al. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy. J Hepatol 2015;62(4):897–904.

iLIVER
Pages 56-66
Cite this article:
Li Z, Zhang Z, Yu J, et al. Imaging of pregnancy-related liver diseases. iLIVER, 2023, 2(1): 56-66. https://doi.org/10.1016/j.iliver.2023.02.003

498

Views

0

Crossref

Altmetrics

Received: 05 December 2022
Revised: 19 February 2023
Accepted: 20 February 2023
Published: 04 March 2023
© 2023 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return